Introduction

Running-specific prostheses (RSPs) are passive-elastic devices typically made of carbon fiber that attach to a socket that surrounds the residual limb. The use of RSPs enable athletes with transtibial amputations (TTAs) to compete in running events including the Olympic games. RSP models are generally C-shaped or J-shaped. C-shaped RSPs attach distal to the socket and are recommended for distance running1 (e.g. 10 km, half marathon, and marathon) and J-shaped RSPs attach posterior to the socket and are recommended for sprinting1 (e.g. 100 m, 200 m, and 400 m). Despite different attachments and shapes, both types of RSPs act in-series with the residual limb. Athletes with TTAs are prescribed an RSP with a manufacturer-recommended stiffness category that is based on his or her body mass and activity level1,2,3. Greater stiffness categories correspond with stiffer RSPs while considering prosthetic model4. Further, for an athlete with a unilateral TTA, RSP height is set based on the athlete’s contralateral unaffected leg length, stride kinematics, and their prosthetist’s and personal preference5. The height of a C-shaped RSP is adjusted by shortening or lengthening the pylon that connects the RSP to the socket, while the height of a J-shaped RSP is adjusted by changing its mounting position posterior to the socket (Fig. 1). An athlete’s unloaded RSP height is adjusted so that their affected leg (AL) length is 2–8 cm taller than their unaffected leg (UL) length6,7. The RSP configuration (i.e. model, stiffness category, height) used by athletes with TTAs likely affects their running performance, which is well-correlated with the maximum running velocity that an athlete can attain8.

Figure 1
figure 1

(A) Freedom Innovations Catapult (FDM), (B) Össur Cheetah Xtend (OSR), and (C) Ottobock 1E90 Sprinter (OBK) running-specific prosthetic models attached in-series to a carbon fiber socket that encompasses the residual limb. The height of the prosthesis is adjusted using a pylon or height adjustment bracket.

Running velocity equals the product of stride frequency and stride length, where a stride is two steps and a step is the period of ground contact and subsequent aerial time7. Step frequency equals the number of steps in a given period of time, and step length equals the forward distance traveled by the centre of mass (CoM) relative to the ground with each step. At a given velocity, step length can be expressed as the product of the average vertical ground reaction force (GRF) applied during ground contact normalized to body weight and contact length (the product of contact time and forward velocity), which is the forward distance traveled by the CoM during ground contact9. Thus, running velocity equals the product of step frequency, stance average vertical GRF, and contact length. Runners increase step frequency by decreasing ground contact time and primarily increase step length by applying greater vertical GRFs on the ground10. Greater vertical GRFs increase the vertical CoM velocity at the end of ground contact, resulting in longer aerial time, and thus increasing the forward CoM distance traveled for each step at a given running velocity. However, at a given velocity, an increase in step length or frequency is counteracted by a decrease in the other parameter10. For example, an increase in vertical velocity at the end of ground contact would increase step length but also increase step time, which would decrease step frequency, and not change running velocity. Non-amputees and athletes with TTAs exhibit directionally similar changes in stance average vertical GRFs and spatiotemporal variables to increase running velocity, but biomechanics differ between the AL versus UL6,7.

The biomechanics of level-ground running are well represented by a spring-mass model11,12,13,14. In this model, the leg is represented by a massless linear spring, and body mass is represented by a point mass. Leg stiffness equals the peak vertical GRF divided by CoM displacement along the leg. The relationship between leg stiffness and running velocity is unclear: non-amputees either maintain or increase leg stiffness as running velocity increases6,15,16. Athletes with unilateral TTAs decrease AL stiffness, while UL stiffness remains constant from 3.0 m/s up to maximum running velocity (vmax)6, thus leg stiffness values between the AL and UL are more asymmetric at faster velocities.

Previous studies found no relationship between biomechanical asymmetries (i.e. differences in spatiotemporal, GRF, and stiffness variables between legs) and sprint performance in non-amputees17,18,19. However, it is possible that the anatomical differences between the legs of an athlete with a unilateral TTA result in larger biomechanical asymmetries compared to non-amputees: for example, reported values of asymmetries in non-amputee sprinters vary between 1.1% (step frequency)18 and 1.3% (step length)18, and 4.2% (ground contact time)17 and 4.9% (aerial time)17. On the other hand, previous studies have shown that athletes with unilateral TTAs apply 9% lower stance average vertical GRFs with their AL compared to UL using a typical RSP configuration across a range of speeds up to vmax7. Because step length equals the product of contact length and stance average vertical GRF at a given velocity9, if one leg has a limited ability to apply GRFs compared to the other leg, step length will be reduced. If the reduced step length is not compensated by an increase in step frequency, this would limit vmax. Additionally, athletes with unilateral TTAs have an 8% slower step frequency at vmax for their AL compared to their UL, while ground contact time/length does not differ between legs7. Further, Beck et al.20 found that more symmetric peak vertical GRFs between the AL and UL of athletes with unilateral TTAs reduced the metabolic cost of running at 2.5–3.0 m/s. However, the effects of different RSP configurations on biomechanical asymmetry and vmax in athletes with unilateral TTAs are not yet fully understood.

Given the subjective nature of RSP prescription, the purpose of our study was to quantify how use of different RSP model, stiffness, and height configurations affect maximum running velocity (vmax) and the underlying biomechanics in athletes with a unilateral TTA. Due to the lack of quantifiable information about how use of different RSP models affect vmax, we tested the null hypothesis that prosthetic model would not affect vmax. Because non-amputees maintain or increase leg stiffness with faster running velocity6,15,16, we hypothesized that use of stiffer RSPs would increase vmax. Due to the tradeoff between step frequency and step length10, we tested the null hypothesis that vmax would be independent of RSP height. Moreover, we hypothesized that use of the optimal RSP model, stiffness, and height combination would result in faster step frequencies, greater stance average vertical GRFs, longer contact lengths, and the fastest vmax. Based on the idea that a limitation in one leg can reduce overall performance, we also hypothesized that athletes would exhibit less asymmetric biomechanics (step frequency, stance average vertical GRF, and contact length) using the optimal RSP configuration.

Methods

Participants

Ten athletes with a unilateral TTA (Table 1) gave written informed consent prior to participation. The protocol was approved by the Colorado Multiple Institutional Review Board and the United States Army Medical Research and Materiel Command Human Research Protection Office. All research was performed in accordance with relevant guidelines and regulations. Participants reported no cardiovascular, pulmonary, musculoskeletal, or neurological disease or disorder beyond a TTA.

Table 1 Subject demographics, 100 m personal record (PR), usual running-specific prosthesis (RSP) and shape, and RSP configuration that resulted in the fastest maximum velocity (vmax).

Each participant first completed an alignment and accommodation session lasting about 4 hours. A certified prosthetist aligned each participant with three different prosthetic models: Freedom Innovations Catapult FX6 (FDM; Irvine, CA), Ottobock 1E90 Sprinter (OBK; Duderstadt, Germany), and Össur Cheetah Xtend (OSR; Reykjavik, Iceland). We chose these models because we have previously established the mechanical properties for each model4. FDM is C-shaped, while OBK and OSR are J-shaped (Fig. 1). Each participant was aligned with the manufacturer’s recommended stiffness category (based on body mass) and ±1 stiffness category, and at the manufacturer’s recommended height and ±2 cm. We adjusted the height of FDM (C-shaped RSP) by changing the height of the pylon connecting the socket to the RSP, and we adjusted the height of OBK and OSR (J-shaped RSPs) using custom aluminum brackets (Fig. 1). Some athletes used two different sockets: one socket for the C-shaped RSP (FDM) and a different socket for the J-shaped RSPs (OBK, OSR). During the accommodation session, participants ran using each RSP configuration on a treadmill at self-selected speeds and the prosthetist made adjustments until both the participant and prosthetist were satisfied.

Biomechanical measurements

Each athlete performed sets of running trials consisting of at least 8 strides per trial at constant velocities on a 3D force measuring treadmill (Treadmetrix, Park City, UT). Each series of trials began at 3 m/s, rest was provided between trials, and after each successive trial we incremented treadmill velocity by 1 m/s until the athlete approached their vmax, where we used smaller velocity increments until athletes reached their vmax. Athletes usually lowered themselves from the handrails onto the moving treadmill belt to initiate each trial; however, some athletes stood on the treadmill belt and accelerated at 1.0 m/s2 (treadmill default acceleration that was constant for all athletes) with the treadmill belt until it reached the desired velocity and the trial began. All of the athletes were experienced with treadmill running. vmax was defined as the velocity where athletes took at least 8 strides on the treadmill while maintaining their fore-aft position9. If an athlete could not maintain the velocity for 8 strides, we allowed them to repeat the trial, after ad-libitum rest. For each series of trials, athletes used one of 15 different combinations of RSP model, stiffness, and height. Prosthetic models were FDM, OBK, and OSR. Prosthetic stiffness conditions were the manufacturer recommended stiffness category (based on body mass and high activity level) and ±1 stiffness categories. Prosthetic height conditions were manufacturer recommended height and ±2 cm. We randomized the trial order of RSP model and stiffness category (3 RSP models × 3 stiffness categories = 9 trials). Then for each RSP model, height was only adjusted for the stiffness category that enabled the fastest vmax. We randomly inserted the different height trials into the trial order (3 RSP models × 2 RSP heights = 6 trials). Participants completed a maximum of 3 series of trials per day to minimize any potential effects of fatigue; thus, the entire protocol required at least 5 days. Depending on the feedback of each participant, additional rest days were taken to further minimize fatigue, and the average duration to complete the protocol was 10 days.

Throughout each trial, we measured 3D GRFs at 1000 Hz and filtered them using a 4th order low-pass Butterworth filter with a 30 Hz cutoff. We used these filtered data and a 30 N vertical GRF threshold to detect ground contact and calculate GRF parameters, step kinematics, and leg stiffness for each leg (AL and UL) during each step using a custom MATLAB script (MathWorks, Natick, MA). We determined step time for each leg as the sum of the ground contact time and subsequent aerial time. We calculated contact length as the product of ground contact time and the treadmill velocity. For each variable (step frequency, stance average vertical GRF, contact length, contact time, aerial time, and leg stiffness), we calculated the average of both legs. Participants ran with reflective markers attached to the distal end of their RSP and the fifth metatarsal head of their UL. We tracked the position of these markers at 200 Hz (Vicon Nexus, Oxford, UK), filtered marker position data using a 4th order low-pass Butterworth filter with a 7 Hz cutoff, and used a custom MATLAB script to confirm treadmill belt velocity during each foot- or RSP-ground contact.

We used the mean AL peak resultant GRFs measured in the current study and the reported RSP stiffness values from each device reported by Beck et al.4 (Supplementary Tables 1, 3 and 4) (kRSP) to calculate RSP displacement (ΔRSP):

$$\Delta {\rm{RSP}}=\frac{Peak\,GRF}{{k}_{RSP}}$$
(1)

We calculated leg stiffness (kleg) in kN/m as the ratio between peak vertical GRF and maximum leg displacement (ΔL) during each stance phase for the respective limb:

$${k}_{leg}=\frac{Peak\,vGRF}{\Delta L}$$
(2)

To determine ΔL, we calculated the angle of the leg (relative to vertical) at initial ground contact (contact angle, θ) using running velocity (v), ground contact time (tc), and initial leg length (L0) for each leg:

$$\theta ={\sin }^{-1}(\frac{v{t}_{c}}{2{L}_{0}})$$
(3)

We measured initial UL length (L0) as the distance from the greater trochanter to the floor during standing, and AL length (L0) as the distance from the greater trochanter to the distal end of the unloaded RSP6,7,21. We calculated maximum vertical displacement of the CoM (Δy) by twice integrating the vertical acceleration of the CoM with respect to time22. Then, we used Δy, L0, and θ to calculate ΔL according to McMahon and Cheng12:

$$\Delta L=\Delta y+{L}_{0}(1-\,\cos \,\theta )$$
(4)

We also calculated the symmetry index (SI) for all biomechanical variables of the AL and UL as a ratio between legs, according to Robinson et al.23:

$$SI=\frac{va{r}_{AL}-va{r}_{UL}}{0.5\,(va{r}_{AL}+va{r}_{UL})}$$
(5)

A positive SI means that the value for the AL is greater than the value for the UL, while a negative SI means that the value for the AL is lower than the value for the UL. An SI of zero indicates perfect symmetry between the AL and UL.

Statistical analysis

We used a linear mixed model to analyze the influence of RSP model, stiffness category, and height on vmax. We used a second linear mixed model to analyze the influence of RSP model, actual stiffness (in kN/m), and height on vmax. We used additional linear mixed models to analyze the influence of significant RSP configurations (model, stiffness, and/or height) on both legs’ average and SI of biomechanical variables (step frequency, stance average vertical GRF, contact length, contact time, aerial time, and leg stiffness) while accounting for differences in vmax. We report the fixed effect (β) from each statistically significant association (dependent variable = β independent variable + intercept). We selected linear mixed models, as opposed to simple linear regression analyses, to control for subject variability. Each subject was classified as a random effect, while the independent variables were classified as fixed-effect variables. Linear mixed models are particularly useful in a repeated measures design because they take into account the lack of independence between observations within the same athlete using different RSP configurations24. For all linear mixed models, RSP model was classified as a categorical variable, while the stiffness category, actual stiffness, height and all biomechanical variables were classified as continuous variables. We also used one-sample t-tests to compare SI values to perfect symmetry between legs (SI = 0). We used a significance level of p < 0.05. When applicable, we implemented Bonferroni corrections to account for multiple comparisons. We performed all statistical tests using RStudio (RStudio Inc., Boston, MA).

Results

The vmax (avg ± SD) for athletes with unilateral TTAs using OBK, OSR, and FDM RSPs were 8.18 ± 1.00 m/s, 7.67 ± 1.25 m/s, and 7.39 ± 1.30 m/s, respectively. Thus, RSP models will be referred to as OBK1, OSR2, and FDM3 to denote order based on vmax reached when using each model (1 = fastest, 2 = middle, 3 = slowest). Compared to use of the C-shaped FDM3 RSP, vmax was 10.7% (β1 = 0.82, p < 0.05) and 3.8% (β2 = 0.36, p < 0.05) faster when athletes with unilateral TTAs used J-shaped OBK1 and OSR2 RSPs, respectively. Additionally, use of an OBK1 RSP resulted in 6.6% (β1 = 0.46, p < 0.05) faster vmax compared to use of an OSR2 RSP. RSP stiffness category, actual stiffness, and height did not influence vmax (p = 0.72, p = 0.37, and p = 0.11, respectively; Fig. 2) and there were no significant interactions among RSP model, stiffness, and height for vmax (p > 0.05).

Figure 2
figure 2

Average ± SEM maximum velocity (vmax) when athletes used the Ottobock 1E90 Sprinter (OBK1), Össur Cheetah Xtend (OSR2), and Freedom Innovations Catapult (FDM3) running-specific prosthetic (RSP) models with (A) stiffness categories (Cat) that are recommended (Rec), one Cat less stiff (−1) and one Cat more stiff (+1) than Rec, and (B) heights that are recommended (Rec), two cm shorter (−2) and two cm taller (+2) than Rec height. There was no effect of stiffness category or height on vmax. Use of the OBK1 RSP resulted in the fastest vmax, followed by use of OSR2, and use of FDM3 RSPs.

When accounting for differences in vmax, we found that use of FDM3 resulted in 3.4% faster step frequencies than use of OBK1 and OSR2 RSPs (β1 = −0.088 and β2 = −0.088, both p < 0.05; Fig. 3A, Table 2), and the step frequencies were non-different between use of OBK1 and OSR2 RSPs (p = 0.99). Use of OSR2 resulted in 2.3% and 4.6% greater stance average vertical GRF than use of OBK1 and FDM3 RSPs, respectively (β1 = 0.040 and β3 = 0.080, both p < 0.05; Fig. 3B, Table 2), and use of OBK1 resulted in 2.3% greater stance average vertical GRF than use of FDM3 RSPs (β3 = 0.040, p < 0.05). Use of OBK1 and FDM3 RSPs resulted in 4.4% longer contact lengths than use of OSR21 = 0.021 and β3 = 0.021, both p < 0.05; Fig. 3C, Table 2), but there was no significant difference in mean contact length between use of OBK1 and FDM3 RSPs (p = 0.98).

Figure 3
figure 3

Maximum velocity (vmax) as a function of (A) step frequency, (B) stance average vertical ground reaction force (vGRF), and (C) contact length when using Ottobock 1E90 Sprinter (OBK1), Össur Cheetah Xtend (OSR2), and Freedom Innovations Catapult (FDM3), running-specific prosthetic models. Each individual data point represents the average value between the affected and unaffected legs for a single trial. Trend lines represent linear regressions for each prosthetic model. Coefficients of determination for linear regressions are shown in Table 2.

Table 2 Coefficients of determination (R-squared) for statistically significant (p < 0.05) linear regressions between biomechanical variables and maximum velocity (Figs. 3 and 4) when using Ottobock 1E90 Sprinter (OBK1), Össur Cheetah Xtend (OSR2), and Freedom Innovations Catapult (FDM3) running-specific prosthetic models. - indicates the biomechanical variable had no effect on maximum running velocity.

When accounting for differences in vmax, we found that use of OSR2 resulted in 1.4% and 1.6% shorter ground contact times than use of OBK1 and FDM3 RSPs, respectively (β1 = 0.0027 and β3 = 0.0031, both p < 0.05; Fig. 4A, Table 2). However, there were no significant differences in contact times when athletes used OBK1 compared to FDM3 RSPs (p = 0.73). Use of OBK1 and OSR2 resulted in 3.7% and 5.7% longer aerial times than use of FDM3 RSPs, respectively (β1 = 0.0054 and β2 = 0.0083, both p < 0.05) and there were no significant differences in aerial times when athletes used OBK1 compared to OSR2 RSPs (p = 0.057; Fig. 4B, Table 2). Use of OBK1 resulted in 6.4% lower leg stiffness than use of OSR2 and FDM3 RSPs (β2 = 1.109 and β3 = 1.098, both p < 0.05) and there was no significant difference in leg stiffness between use of OSR2 and FDM3 RSPs (p = 0.97; Fig. 4C, Table 2).

Figure 4
figure 4

Maximum velocity (vmax) as a function of (A) contact time, (B) aerial time, and (C) leg stiffness when using Ottobock 1E90 Sprinter (OBK1), Össur Cheetah Xtend (OSR2), and Freedom Innovations Catapult (FDM3), running-specific prosthetic models. Each individual data point represents the average value between the affected and unaffected legs for a single trial. Trend lines represent linear regressions for each prosthetic model. Coefficients of determination for linear regressions are shown in Table 2.

We found that step frequency SI was less than zero when using all three RSPs (all p < 0.05; Table 3); on average, step frequency was 6.4% slower for the AL compared to UL. However, there were no differences in step frequency SI between RSP models (OBK1 vs. OSR2: p = 0.31; OBK1 vs. FDM3: p = 0.72; OSR2 vs. FDM3: p = 0.16). Stance average vertical GRF SI was less than zero across RSP conditions (all p < 0.05); on average stance average vertical GRFs were 6.2% lower for the AL compared to UL (Fig. 5, Table 3). However, use of OBK1 and OSR2 resulted in stance average vertical GRF SIs that were 0.078 and 0.105 more symmetric, respectively, compared to use of FDM3 RSPs (both p < 0.05). There was no significant difference in stance average vertical GRF SI between use of OBK1 and OSR2 RSPs (p = 0.16). Contact length SI was greater than zero when using all three RSPs (all p < 0.05); on average, contact lengths were 7.2% longer for the AL compared to UL. However, use of OSR2 resulted in contact length SIs that were 0.045 and 0.022 more symmetric compared to use of OBK1 and FDM3 RSPs, respectively (both p < 0.05), and use of FDM3 resulted in contact length SIs that were 0.023 more symmetric compared to use of OBK1 (p < 0.05).

Table 3 Average symmetry indices (SI) between the affected leg (AL) and unaffected leg (UL) for biomechanical variables when using Ottobock 1E90 Sprinter (OBK1), Össur Cheetah Xtend (OSR2), and Freedom Innovations Catapult (FDM3) running-specific prosthetic models. A positive SI means that the value for the AL is greater than the value for the UL, a negative SI means that the value for the UL is greater than the value for the AL, and an SI of zero indicates perfect symmetry between AL and UL. All SIs are significantly different than zero (p < 0.05).
Figure 5
figure 5

Representative vertical ground reaction force (vGRF) traces for the affected leg (AL) and unaffected leg (UL) when using (A) Ottobock 1E90 Sprinter (OBK1), (B) Össur Cheetah Xtend (OSR2), and (C) Freedom Innovations Catapult (FDM3) running-specific prosthetic models (recommended stiffness category and height) at maximal running velocity (OBK1 = 7.46 m/s, OSR2 = 7.43 m/s, FDM3 = 7.00 m/s).

We found that contact time SI was greater than zero when using all three RSPs (all p < 0.05); on average, ground contact times were 5.3% longer for the AL compared to UL. Use of OBK1 resulted in contact time SIs that were 0.047 and 0.031 more asymmetric than use of OSR2 and FDM3 RSPs, respectively (both p < 0.05). Further, use of OSR2 resulted in contact time SIs that were 0.016 more symmetric than use of FDM3 RSPs (p < 0.05). Aerial time SI was greater than zero when using all three RSPs (all p < 0.05); on average aerial times were 9.4% longer for the AL compared to UL. Use of OSR2 resulted in aerial time SIs that were 0.061 and 0.062 more asymmetric than use of OBK1 and FDM3 RSPs, respectively (both p < 0.05). There was no significant difference in aerial time SI between use of OBK1 and FDM3 RSPs (p = 0.79). Finally, leg stiffness SI was less than zero when using all three RSPs (all p < 0.05); on average, leg stiffness was 15.7% lower for the AL compared to UL. Use of OBK1 resulted in leg stiffness SIs that were 0.052 and 0.090 more asymmetric than use of OSR2 and FDM3 RSPs, respectively (both p < 0.05). There was no difference in leg stiffness SI between use of OSR2 and FDM3 RSPs (p = 0.18).

Discussion

We reject our initial hypothesis because RSP model, but not stiffness or height, affects maximum running velocity in athletes with unilateral TTAs. Therefore, we only considered RSP model as a factor in determining the optimal configuration. Specifically, use of OBK1 resulted in the fastest vmax, followed by use of OSR2, and FDM3 RSPs. These results are in agreement with a previous study of running at 2.5–3.0 m/s for athletes with unilateral TTAs, which found that RSP model, but not stiffness or height, affects metabolic cost20. Thus, in addition to optimizing distance running performance (i.e. metabolic cost), results of the present study suggest that use of a J-shaped RSP model could also improve sprinting performance (i.e. vmax) for athletes with unilateral TTAs compared to use of a C-shaped RSP.

There were biomechanical similarities when athletes with a TTA used OBK1 and OSR2 that were not present when they used FDM3 RSPs that may explain the differences in vmax elicited by use of different RSP models. Due to the inherent relationships between velocity and the biomechanical variables we investigated, we controlled for differences in velocity and determined the biomechanics elicited by use of different RSP models. When controlling for vmax, use of J-shaped RSPs (OBK1 and OSR2) resulted in greater stance average vertical GRF compared to the C-shaped RSP (FDM3). Additionally, compared to use of FDM3, use of OBK1 and OSR2 RSPs resulted in slower step frequencies due to longer aerial times together with shorter (OBK1) or similar (OSR2) ground contact times. These biomechanical findings may be attributable to RSP shape; OBK1 and OSR2 are J-shaped RSPs while FDM3 is C-shaped. Compared to C-shaped RSPs, J-shaped RSPs have about 1% lower hysteresis and are wider4,20,21. The lower hysteresis from J-shaped RSPs could result in greater vertical CoM velocity at the end of the stance phase, and a longer aerial time for a given contact time, which would decrease step frequency. The wider geometry of J-shaped RSPs could enhance stability during running. When balance is perturbed, individuals with TTAs increase step frequency and decrease step length during walking, presumably to minimize the risk of falling25. It is possible that use of the narrower C-shaped RSPs resulted in greater medio-lateral instability that required athletes to run with increased step frequency compared to use of wider J-shaped RSPs. It is also possible that the alignment of the J-shaped RSPs enables a more vertical leg position during the stance phase compared to the C-shaped RSP. This could allow the leg to be more closely aligned with the GRF vector, resulting in a better effective mechanical advantage26 and greater stance average vertical GRFs. Further, non-amputees achieve faster running speeds by producing greater stance average vertical GRF9. Our results show that the ability to generate greater stance average vertical GRFs may also be important for athletes with a TTA to achieve faster running speeds, because use of J-shaped RSPs resulted in faster vmax and higher stance average vertical GRFs compared to use of a C-shaped RSP.

We also found some biomechanical differences between use of the two different J-shaped RSPs (OBK1 and OSR2) that could explain differences in vmax. Use of OBK1 resulted in lower stance average vertical GRFs and longer contact lengths than use of OSR2 RSPs when accounting for velocity. These differences were offset, and step lengths were similar when using OBK1 and OSR2 RSPs. Although step frequencies were similar when using OBK1 and OSR2 RSPs, contact times were longer (p < 0.05) and aerial times were numerically but not statistically shorter with use of OBK1 compared to OSR2 RSPs (p = 0.057). Additionally, use of OBK1 resulted in lower leg stiffness than use of OSR2 RSPs. These differences between RSP models could be due to variations in RSP geometry or alignment4,20,21,27 or differences in curvature between OBK1 and OSR2 RSPs (Fig. 6). Similar to alignment’s effect on stance average vertical GRF, perhaps the curvature of the OSR2 RSP enables a more vertical leg position during the stance phase compared to the OBK1 RSP. This could allow the leg to be better aligned with the GRF vector, resulting in greater stance average vertical GRF despite a shorter contact time. A more vertical leg position during initial ground contact would also lead to a smaller leg sweep angle, and thus shorter contact length and contact time. Additionally, a smaller leg sweep angle would decrease leg spring displacement during the stance phase (Eq. 4), which would increase leg stiffness, assuming peak vertical GRF is held constant. Therefore, differences in RSP geometry/curvature or alignment could explain why stance average vertical GRFs were lower, contact lengths and contact times were longer, and leg stiffness was lower with use of OBK1 compared to OSR2. Thus, future studies that determine the effects of RSP geometry/curvature and alignment are warranted to better understand the underlying biomechanical determinants of vmax.

Figure 6
figure 6

Lateral view of the J-shaped running specific prostheses (RSPs) showing differences in curvature. Ottobock 1E90 Sprinter (OBK1) is shown in front (black) and Össur Cheetah Xtend (OSR2) is shown behind (yellow).

Our results partially support the hypothesis that the optimal RSP configuration would elicit more symmetric biomechanics. While considering differences in vmax, RSP model did not affect step frequency symmetry, suggesting that step frequency symmetry may not be important for attaining faster vmax. In contrast, RSP model did affect stance average vertical GRF symmetry. AL stance average vertical GRFs were, on average, 6.2% lower than UL stance average vertical GRFs with use of all three RSP models at vmax. This finding is similar to a previous study that found AL stance average vertical GRFs were 7.7% lower than UL stance average vertical GRFs at vmax7. In the present study, AL stance average vertical GRFs were 3.6%, 2.9%, and 12.2% lower than UL stance average vertical GRFs when using OBK1, OSR2, and FDM3 RSPs, respectively. Use of OBK1 and OSR2 elicited faster vmax than use of FDM3 RSPs and stance average vertical GRFs were more symmetric with use of OBK1 and OSR2 compared to FDM3 RSPs. This suggests that stance average vertical GRF symmetry may influence vmax. RSP model also influenced contact length symmetry. AL contact lengths were, on average, 7.2% longer than UL contact lengths with use of all three RSP models at vmax. This contrasts with a previous study that found no difference in contact length between the AL and UL when athletes with unilateral TTA ran at vmax7. However, contact lengths were least symmetric with use of OBK1, suggesting that contact length symmetry may not influence vmax. Use of the OBK1 RSP resulted in the most asymmetric and lowest average leg stiffness. Because use of the OBK1 RSP elicited the fastest vmax, this suggests that lower average leg stiffness, but not leg stiffness symmetry, may influence vmax in athletes with unilateral TTAs. It is possible that lower leg stiffness results in a greater amount of time to generate force on the ground, which leads to faster vmax. A previous study found that AL leg stiffness was 27% lower than UL leg stiffness at a maximum velocity of 9.5 m/s6. Similarly, we found that AL leg stiffness was 13–22% lower than UL leg stiffness at vmax across all configurations at an average vmax of 8.32 m/s. Overall, our results suggest that RSP configurations that result in more symmetric stance average vertical GRFs have the strongest influence on vmax.

In the present study, we determined the effects of using fifteen different RSP configurations on vmax and the underlying biomechanics used to achieve these velocities. However, a potential limitation of this study is that some athletes used two different sockets to complete the protocol. Athletes used one socket for J-shaped RSPs (OBK1, OSR2) and a different socket for the C-shaped RSP (FDM3), which could have contributed to different amounts of residual limb movement within the socket, and potentially affected running biomechanics21. The mass of each RSP (OBK1: 675 g, OSR2: 750 g, FDM3: 510 g)1,2,3, in addition to the different sockets and attachments, may have affected the results. Specifically, different mass and therefore moment of inertia of the AL, could potentially affect leg swing time and step frequency. However, Grabowski et al.7 found no difference in vmax or in leg swing time of the AL when adding up to 300 g to the distal end of the RSP of athletes with unilateral TTAs compared to the same RSP with no added mass. We found that use of the FDM3 RSP resulted in 3.4% faster step frequencies than OBK1 and OSR2 RSPs yet use of the FDM3 RSP did not elicit the fastest vmax.

Seven of the athletes involved this study typically use J-shaped RSPs for competition compared to three athletes who typically use C-shaped RSPs (Table 1). This familiarity could have affected our results. However, for nine athletes, irrespective of their usual RSP, J-shaped RSPs resulted in the fastest maximum velocity (Table 1). Only subject 2, who usually runs using a J-shaped RSP, had a faster vmax using the C-shaped FDM3. For all 3 of the subjects who usually run using a C-shaped RSP, use of the J-shaped RSPs resulted in a faster vmax.

The spring-mass model has been used to calculate leg stiffness at running speeds ranging from 3.8 m/s13 to 8.7 m/s28 and up to 12.3 m/s29. Clark et al.30 found that the vertical GRF trace is not symmetric during ground contact for professional non-amputee sprinters, which suggests that the assumptions for calculating leg stiffness using the spring-mass model may be violated. We found that the vertical GRF trace for the UL is not symmetric during ground contact (Fig. 5), and thus the leg stiffness of the UL may not be accurately represented by the spring-mass model. These differences may limit our calculations of leg stiffness for the UL and the leg stiffness symmetry index comparing UL and AL leg stiffness. However, our findings are similar to those of McGowan et al.5, who calculated leg stiffness of the UL using the spring-mass model at speeds between 3.0 and 9.5 m/s.

Some athletes lowered themselves from the handrails onto the moving treadmill belt to initiate each trial while others stood on the treadmill and accelerated with the treadmill belt until it reached the desired velocity. Use of these different strategies is unlikely to influence vmax because the treadmill accelerates at 1.0 m/s2 and athletes used the same strategy for each RSP configuration. Additionally, the systematic trial order of progressively increasing velocity with each RSP configuration may have induced fatigue. To reduce any potential effects of fatigue, we allowed athletes rest ad libitum, and limited each day of testing to three sets of trials. The initial accommodation session was approximately four hours, but a longer accommodation period (multiple days/weeks) may have allowed athletes to reach a faster vmax for each RSP configuration. Future studies are needed to determine how athletes accommodate to RSPs, and how accommodation time relates to performance.

We found that RSP height did not significantly affect vmax (p = 0.11), but it is possible that changes of ±2 cm were not enough to significantly affect vmax. However, ±2 cm changes in RSP height were noticeable by each athlete, and greater RSP height changes could have resulted in injury. The average maximum running velocity for all configurations in the present study (8.32 m/s) is similar to those reported previously for athletes with unilateral TTAs running on a treadmill (8.82 m/s and 8.75 m/s)6,7. Future studies are needed to investigate the effects of using different RSP configurations on joint mechanics and muscle activation patterns. These parameters could help to further explain differences in vmax among RSP configurations by revealing changes in effective mechanical advantage or ability to produce muscle force during the stance phase. Future studies should also investigate the effects of different RSP configurations on the start and acceleration phase of sprint races, to determine if the RSP configuration that allows for the fastest vmax is also the configuration that allows for a better start and acceleration, i.e. for a better racing performance.

Conclusions

Athletes with unilateral TTAs reach different maximum running velocities when using different RSP models. Specifically, use of the J-shaped OBK1 resulted in the fastest vmax, followed by use of the J-shaped OSR2, and C-shaped FDM3 RSPs. RSP stiffness and height do not have a significant effect on vmax in athletes with unilateral TTAs. While controlling for velocity, use of J-shaped versus C-shaped RSPs resulted in greater stance average vertical ground reaction forces, slower step frequencies, and longer step lengths. Stance average vertical ground reaction forces were less asymmetric, while contact time and leg stiffness were more asymmetric when using J-shaped versus C-shaped RSPs.